Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 125.63M P/E - EPS this Y - Ern Qtrly Grth -
Income -333.56M Forward P/E - EPS next Y 44.40% 50D Avg Chg -4.00%
Sales 544.09M PEG - EPS past 5Y - 200D Avg Chg -78.00%
Dividend N/A Price/Book 0.17 EPS next 5Y - 52W High Chg -93.00%
Recommedations 2.00 Quick Ratio 0.71 Shares Outstanding 188.33M 52W Low Chg 21.00%
Insider Own 81.43% ROA -10.14% Shares Float 17.10M Beta 0.55
Inst Own 4.98% ROE -77.80% Shares Shorted/Prior 95.94K/116.76K Price 1.35
Gross Margin 80.24% Profit Margin -66.77% Avg. Volume 711,904 Target Price 4.18
Oper. Margin -49.50% Earnings Date - Volume 62,646 Change -3.57%
About YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

YS Biopharma Co., Ltd. News
04/29/24 YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
04/22/24 YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript
04/19/24 YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
04/18/24 YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
04/16/24 YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
04/09/24 YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
04/03/24 YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
03/05/24 YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
02/22/24 YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
02/18/24 /C O R R E C T I O N -- YS Biopharma Co., Ltd./
02/14/24 YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance
02/14/24 YS Biopharma Announces Appointment of New Directors
02/12/24 YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.
02/09/24 YS Biopharma Announces US$40 Million Private Placement Financing
02/08/24 Shareholders of YS Biopharma Announce an Extraordinary General Meeting
01/24/24 Diamond Equity Research Releases Update Note on YS Biopharma Co., Ltd. (NASDAQ: YS)
01/22/24 YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
01/08/24 YS Biopharma Announces Changes to its Board Committees
12/20/23 YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting
11/15/23 When Can We Expect A Profit From YS Biopharma Co., Ltd. (NASDAQ:YS)?
YS Chatroom

User Image TimmyTheBull Posted - 04/30/24

$YS

User Image Kululu Posted - 04/30/24

$YS what a sick piece of shit this stock is

User Image steelwheels09 Posted - 04/30/24

$YS YS has been granted another 180 days to meet compliance which should be not a problem with what is cing down the pipeline ....

User Image Stock_Titan Posted - 04/29/24

$YS $SMIH YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule https://www.stocktitan.net/news/YS/ys-biopharma-receives-additional-180-day-extension-by-nasdaq-to-d8pmyizoyepy.html

User Image TimmyTheBull Posted - 04/25/24

$YS next-generation PIKA Rabies Vaccine that will be used globally πŸ‘€πŸ‘€πŸ‘€πŸ‘€

User Image FerengiBob Posted - 04/23/24

$YS

User Image TimmyTheBull Posted - 04/23/24

$YS dropped to $0.70s after expected bad ER, on watch for more upward movement from here, super sensitive stock with tiny float

User Image steelwheels09 Posted - 04/22/24

$YS let's get back to business here this week . Looking for $1 +

User Image dirty_Sanchez Posted - 04/21/24

$YS Looking like it’s time to fly. It’s about damn time! LFG!!!

User Image Kululu Posted - 04/19/24

$YS this cuck bastard ceo will delist from nasdaq voluntarily. I am telling you. That’s where it’s heading.

User Image TwentyNickels Posted - 04/19/24

$YS looks good πŸ‘

User Image buythedipfillurlip Posted - 04/19/24

$YS the boat is loaded to the brim after today. Ready to sail, let's get it.

User Image Kululu Posted - 04/19/24

$YS cuck ceo cares only about lining his pockets.

User Image Kululu Posted - 04/19/24

$YS I told you that cuck ceo will have nothing to say. After spending millions on covid 19 trial all on a sudden they are not interested in anymore. Then what the hell they did for past three years in this study recruiting almost 6000 volunteers in six different sites. All money went to vacuum. They also did not mention about other ys on 0001 study which has been going for years. I was afraid of this earnings call and it delivered as I expected. These guys won’t even take questions during calls. They have an dumbass analyst called diamond who asks a premade question and they get away with the answer

User Image Djstrebs Posted - 04/19/24

$YS dips being scooped up, this loss was to be expected. Shorts would like yours shares.. will you oblige?

User Image Stock_Titan Posted - 04/19/24

$YS YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 https://www.stocktitan.net/news/YS/ys-biopharma-announces-unaudited-financial-results-for-the-first-ttrpdytndchd.html

User Image ElleFuller Posted - 04/18/24

$SINT some buying action before close? Also bought some $HOLO and will be watching $YS in PM

User Image ElleFuller Posted - 04/18/24

$YS watching

User Image buythedipfillurlip Posted - 04/18/24

$YS volume pushing, green before close?πŸ‘€

User Image Sydney_Sweeneys_Bra Posted - 04/18/24

$YS so I guess .92 is wishful thinking for today, eh?

User Image Kululu Posted - 04/18/24

$YS asshole stock

User Image Stock_Titan Posted - 04/18/24

$YS YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine https://www.stocktitan.net/news/YS/ys-biopharma-granted-phase-i-clinical-trial-license-of-therapeutic-zy2iayqty2f3.html

User Image Djstrebs Posted - 04/18/24

$YS

User Image dojidad Posted - 04/17/24

$YS

User Image TimmyTheBull Posted - 04/17/24

$YS volume surging, won’t take much to take offπŸ”₯πŸ”₯πŸ”₯πŸ”₯πŸ’ŽπŸ’ŽπŸ’ŽπŸ’Ž

User Image Djstrebs Posted - 04/17/24

$YS Volume

User Image Modeezy23 Posted - 04/16/24

$YS primed and ready to goπŸš€

User Image MaxPowerShaft Posted - 04/16/24

$YS @Kululu what makes you think so? stock is up over 100% since end of February

User Image Kululu Posted - 04/16/24

$YS another huge drop is coming since that dumbass CEO is going to announce depressing earnings results with no progression on the clinical pipeline.

User Image Kululu Posted - 04/16/24

$YS @CapnCrunchyPants can I make some comments please?

Analyst Ratings
Noble Capital Markets Outperform Nov 13, 23